stars 1 stars 2 stars 3

Oryzon Genomics S.A. is the first Spanish Biomarker and Target Discovery Company with an In-Vitro Diagnostics and Therapeutic R&D pipeline focused in oncology and neurodegenerative diseases.

Crystax Pharmaceuticals / Oryzon Genomics Questions

The Crystax Pharmaceuticals / Oryzon Genomics annual revenue was $9.1 million in 2026.

Tamara Maes is the Founder and Shareholder of Crystax Pharmaceuticals / Oryzon Genomics.

44 people are employed at Crystax Pharmaceuticals / Oryzon Genomics.

Crystax Pharmaceuticals / Oryzon Genomics is based in Cornella de Llobregat, Catalonia.

The NAICS codes for Crystax Pharmaceuticals / Oryzon Genomics are [541711, 54161, 541612, 54171, 5416, 54, 5417, 325, 32, 541].

The SIC codes for Crystax Pharmaceuticals / Oryzon Genomics are [283, 28].

Top Crystax Pharmaceuticals / Oryzon Genomics Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users